Table 4. Effect of Treatment on Primary and Secondary Outcomes at 3 Months.

Variablea	Control (N = 12)	Intervention (N = 11)	P-Valu
End A1c, %	8.2 ± 1.9	7.7 ± 1.1	0.79
Change in A1c (Post - Pre, %)	-1.0 ± 2.2	-2.0 ± 1.3	0.02
Change in A1c (% Reduction)	-9.1 ± 17.8	-20.3 ± 11.9	0.04
A1c < 7%, no.	2 (9.1)	2 (9.1)	NS
Blood glucose < 70 mg/dL	0.1 ± 0.3	0	NS
Blood glucose > 180 mg/dL	1.9 ± 1.6	1.7 ± 1.2	0.97
Hypoglycemic events/week, no.	0.8 ± 1.0	0.2 ± 0.2	0.08
Hyperglycemic events/week, no.	2.1 ± 3.8	0.1 ± 0.2	0.04
Hospitalizations, no.	0.2 ± 0.6	0	NS
Emergency room visits, no.	0.4 ± 1.2	0.1 ± 0.3	NS
Testing per day, no.	2.2 ± 1.3	1.5 ± 1.0	0.18
Medication adherence rate, %	78.0 ± 13.8	87.7 ± 11.7	NS

^aValues are expressed as number (%) and means ± standard deviations

^bNot significant, P > 0.05